Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMers is a medical device company that specialized in the development of advanced polymer composite materials for the orthodontic industry. The company's primary innovation was the SimpliClear system, which utilized proprietary translucent materials to create the world's first completely clear orthodontic wire and bracket solution. This technology offered patients a highly aesthetic alternative to traditional metal braces while providing clinicians with the mechanical performance necessary for complex tooth movement. Founded as a spin-off from the National University of Singapore, BioMers successfully commercialized its technology globally before being acquired by Ormco Corporation in 2014. The company's products were specifically designed to address the growing demand for discrete dental treatments among adult patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMers.